Literature DB >> 17641237

Thrombolytic therapy for acute ischemic stroke: the likelihood of being helped versus harmed.

Bart M Demaerschalk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17641237     DOI： 10.1161/STROKEAHA.107.494112

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  7 in total

Review 1.  Current understanding of TRPM7 pharmacology and drug development for stroke.

Authors:  Christine You Jin Bae; Hong-shuo Sun
Journal:  Acta Pharmacol Sin       Date:  2012-07-23       Impact factor: 6.150

2.  Assessment and improvement of figures to visually convey benefit and risk of stroke thrombolysis.

Authors:  Jigneshkumar Gadhia; Sidney Starkman; Bruce Ovbiagele; Latisha Ali; David Liebeskind; Jeffrey L Saver
Journal:  Stroke       Date:  2010-01-07       Impact factor: 7.914

3.  Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial.

Authors:  Jeffrey L Saver; Jeffrey Gornbein; James Grotta; David Liebeskind; Helmi Lutsep; Lee Schwamm; Phillip Scott; Sidney Starkman
Journal:  Stroke       Date:  2009-06-04       Impact factor: 7.914

Review 4.  Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis.

Authors:  Sonia Butalia; Alexander A Leung; William A Ghali; Doreen M Rabi
Journal:  Cardiovasc Diabetol       Date:  2011-04-01       Impact factor: 9.951

5.  Surveying the medical literature: five notable articles in general internal medicine from 2008 and 2009.

Authors:  Alexander A Leung; William A Ghali
Journal:  Open Med       Date:  2010-10-05

6.  Early and intermediate prognosis of intravenous thrombolytic therapy in acute ischemic stroke subtypes according to the causative classification of stroke system.

Authors:  Ali Pashapour; Abolfazl Atalu; Mehdi Farhoudi; Ali-Akbar Taheraghdam; Elyar Sadeghi Hokmabadi; Ehsan Sharifipour; Mehdi Najafineshli
Journal:  Pak J Med Sci       Date:  2013-01       Impact factor: 1.088

7.  Inhibition of T cell immunoglobulin and mucin-1 (TIM-1) protects against cerebral ischemia-reperfusion injury.

Authors:  Yueying Zheng; Liqing Wang; Manli Chen; Lu Liu; Aijie Pei; Rong Zhang; Shuyuan Gan; Shengmei Zhu
Journal:  Cell Commun Signal       Date:  2019-08-22       Impact factor: 5.712
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.